Filter Results :

Your search for Diabetes returned 226 reports

Sort by


Diabetes Drugs Markets in China

01 Jul 2015  |  Published by:  Asia Market Info and Dev Co.
China's demand for Diabetes Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, con...

$ 4,000.00

Read More

Gestational Diabetes Global Clinical Trials Review, H1, 2015

20 May 2015  |  Published by:  GlobalData
Summary“Gestational Diabetes Global Clinical Trials Review, H1, 2015" provides data on the Gestational Diabetes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gestational Diabetes. It includes an overview of the trial numbers and their...

$ 2,500.00

Read More

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015

13 May 2015  |  Published by:  Global Markets Direct
Summary‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015’, provides an overview of the Type 1 Diabetes (Juvenile Diabetes)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Type 1 Diabetes (Juvenile Diabetes), complete with compara...

$ 2,000.00

Read More

Global Diabetes Drugs Industry 2015 Market Research Report

10 May 2015  |  Published by:  9Dimen Research
2015 Global Diabetes Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Diabetes Drugs industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).The...

$ 2,850.00

Read More

Global Diabetes Drugs Industry Report 2015

01 May 2015  |  Published by:  QYResearch
The Global Diabetes Drugs Industry Report 2015 is a professional and in-depth study on the current state of the diabetes drugs industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The diabetes drugs market an...

$ 3,600.00

Read More

Thermalin Diabetes, LLC - Product Pipeline Review - 2015

30 Apr 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Thermalin Diabetes, LLC - Product Pipeline Review - 2015’, provides an overview of the Thermalin Diabetes, LLC’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Thermali...

$ 1,500.00

Read More

The National Institute of Diabetes and Digestive and Kidney Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile

27 Apr 2015  |  Published by:  GlobalData
SummaryThe National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is a research institute. It conducts, supports, and coordinates research on many of the most serious diseases affecting public health. The institute focuses on clinical research on the diseases of internal medicine a...

$ 250.00

Read More

Juvenile Diabetes Research Foundation - Medical Equipment - Deals and Alliances Profile

24 Apr 2015  |  Published by:  GlobalData
SummaryJuvenile Diabetes Research Foundation (JDRF) is a biotechnology service provider. The company provides research and development service for type 1 diabetes. It provides grants for diabetes clinical trials to laboratories, educational institutions, and pharmaceutical and medical research compa...

$ 250.00

Read More

Physician Views: Can Intarcia's implantable GLP-1 treatment revolutionise the diabetes market?

20 Apr 2015  |  Published by:  FirstWord
Intarcia has previously suggested that it is the highest-valued privately owned biotech company in history. This claim is heavily built around the potential success of ITCA 650; a matchstick-sized, subcutaneous osmotic mini-pump designed to secrete the GLP-1 agonist exenatide (the active ingredie...

$ 695.00

Read More

FirstView Barriers - An Analysis of Market Barriers in Type 2 Diabetes (EU5)

20 Apr 2015  |  Published by:  FirstWord
What market barriers are influencing the Type 2 Diabetes (T2DM) market? From price to availability to reimbursement factors, FirstView Barriers – An Analysis of Market Barriers in Type 2 Diabetes (EU5) provides insights that can help develop, shape and refine your brand strategies. Also Available...

$ 4,995.00

Read More

FirstView Barriers - An Analysis of Market Barriers in Type 2 Diabetes (US)

20 Apr 2015  |  Published by:  FirstWord
What market barriers are influencing the Type 2 Diabetes (T2DM) market? From price to availability to reimbursement factors, FirstView Barriers – An Analysis of Market Barriers in Type 2 Diabetes (US) provides insights that can help develop, shape and refine your brand strategies. Also Available ...

$ 4,995.00

Read More

Global Continuous Glucose Monitoring System (CGM Market, Integrated Insulin Pumps, MARD, SMBG, Growing Diabetic Population, Type 1&2 Diabetes, Nocturnal Hypoglycemia) Price, Industry Analysis, Market Growth, Market Share, Forecasts 2014 – 2020

10 Apr 2015  |  Published by:  Occams Business Research and Consulting
Global Continuous Glucose Monitoring System (CGM Market, Real Time Monitoring, Integrated Insulin Pumps, Blood Glucose, Manufacturers, Global Health, IPRO Glucose, MARD, SMBG, Growing Diabetic Population, Type 1&2 Diabetes, Nocturnal Hypoglycemia) - Glucose Sensors, Geographical Analysis, Ar...

$ 4,000.00

Read More

Abbott Diabetes Care, Inc. - Medical Equipment - Deals and Alliances Profile

07 Apr 2015  |  Published by:  GlobalData
SummaryAbbott Diabetes Care, Inc. (ADC)formerly known as TheraSense, Inc., discovers, develops, manufactures and markets pharmaceuticals and medical products for personal use and hospital use. Its personal use products include freestyle lite meter, freestyle freedom lite meter, freestyle lite test s...

$ 250.00

Read More

Global Diabetes Drug Market & Pipeline Insight 2015

02 Apr 2015  |  Published by:  KuicK Research
Diabetes market is a rapidly growing segment with numerous products at different stages of clinical pipeline and others at different phases of industry life cycle. Disease incidences are escalating rapidly across the globe due to which high unmet demand has been created and pharmaceutical comp...

$ 2,400.00

Read More

The 2016-2021 World Outlook for Diabetes Monitoring Devices

01 Apr 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the world outlook for diabetes monitoring devices across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the...

$ 995.00

Read More
Total 226 records.